Detalhe da pesquisa
1.
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies.
Diabetes Obes Metab
; 23(2): 549-560, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145944
2.
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2.
Diabetes Obes Metab
; 22(11): 2151-2160, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32691513
3.
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting ß-hydroxybutyrate levels in a phase IIa pilot study.
Diabetes Obes Metab
; 19(6): 814-821, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28098426
4.
Role of miR-155 in the pathogenesis of herpetic stromal keratitis.
Am J Pathol
; 185(4): 1073-84, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25700796
5.
Codelivery of TGFß and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors.
NAR Cancer
; 6(1): zcad059, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204925
6.
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.
Am J Pathol
; 181(2): 525-34, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22659469
7.
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
Invest New Drugs
; 31(5): 1345-54, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801303
8.
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.
Invest New Drugs
; 29(6): 1395-405, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20607586
9.
Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes.
Sci Rep
; 10(1): 22396, 2020 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33372185
10.
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.
Lancet Diabetes Endocrinol
; 8(10): 845-854, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946821
11.
Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.
Infect Immun
; 77(1): 367-73, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18955473
12.
Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2.
Diabetes Care
; 42(6): 1081-1087, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967434
13.
Developmental and transcriptional responses of maize to drought stress under field conditions.
Plant Direct
; 3(5): e00129, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245774
14.
The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17.
Infect Immun
; 76(9): 4092-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18573896
15.
Interactions of elongation factor EF-P with the Escherichia coli ribosome.
FEBS J
; 275(4): 671-81, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18201202
16.
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Diabetes Care
; 41(12): 2552-2559, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352894
17.
Map Sensitivity vs. Map Dependency: A Case Study of Subway Maps' Impact on Passenger Route Choices in Washington DC.
Behav Sci (Basel)
; 7(4)2017 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29068371
18.
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.
J Diabetes Complications
; 31(7): 1215-1221, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28284707
19.
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.
Clin J Am Soc Nephrol
; 12(5): 751-759, 2017 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302903
20.
Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels.
J Clin Lipidol
; 11(2): 450-458.e1, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28502502